NIH-funded research NIH-funded research

Creating a new diagnostic tool for quick and accurate biomarker detection.

Official title: Development of a Novel Split Enzyme Diagnostic Platform for Use at the Point of Care

Funded at Clemson University · NIH-11182852 · Data updated 2026-11-12

This study is working on a new, easy-to-use test that can quickly and affordably detect important health markers right where you receive care, helping doctors make better decisions without needing costly lab tests.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$249,000
NIH project number4R00EB034778-02
Project IDNIH-11182852 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals requiring rapid diagnostic testing for various medical conditions that involve biomarker detection.

Less likely to help

Patients with conditions that do not involve detectable biomarkers or those who are not in need of point-of-care testing may not benefit from this research.

What this research studies

This research focuses on developing a novel diagnostic platform that allows for rapid and cost-effective detection of biomarkers directly at the point of care. By utilizing innovative protein-based signaling networks, the project aims to enhance the sensitivity of detecting low concentrations of proteins and small molecules, which are crucial for accurate clinical decision-making. The approach involves combining split enzyme reconstitution, autocatalytic feedback loops, and small molecule biosensors to create a system that can amplify signals for better detection. This could potentially reduce reliance on expensive lab tests and improve the accuracy of diagnoses.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and timely diagnoses for patients, improving treatment outcomes.

How similar studies have gone: Previous research has shown promise in using protein-based signaling for diagnostics, indicating that this approach could be a significant advancement in the field.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Majors, Catherine E. — Clemson University
  • Study coordinator: Majors, Catherine E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.